Posaconazole Patent Expiration
Posaconazole is used for preventing and treating fungal infections in severely immunocompromised patients aged 2 years and older. It was first introduced by Schering Corp
Posaconazole Patents
Given below is the list of patents protecting Posaconazole, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Noxafil | US9493582 | Alkylated cyclodextrin compositions and processes for preparing and using the same | Feb 27, 2033 | Merck Sharp Dohme |
| Noxafil | US9023790 | Posaconazole intravenous solution formulations stabilized by substituted β-cyclodextrin | Jul 04, 2031 | Merck Sharp Dohme |
| Noxafil | US9358297 | Posaconazole intravenous solution formulations stabilized by substituted β-cyclodextrin | Jun 24, 2031 | Merck Sharp Dohme |
| Noxafil | US10117951 | Sulfoalkyl ether cyclodextrin compositions | Mar 13, 2029 | Merck Sharp Dohme |
| Noxafil | US8410077 | Sulfoalkyl ether cyclodextrin compositions | Mar 13, 2029 | Merck Sharp Dohme |
| Noxafil | US9750822 | Sulfoalkyl ether cyclodextrin compositions | Mar 13, 2029 | Merck Sharp Dohme |
| Noxafil | US8263600 | Antifungal composition with enhanced bioavailability |
Apr 01, 2022
(Expired) | Schering |
| Noxafil | US5661151 | Tetrahydrofuran antifungals |
Jul 19, 2019
(Expired) | Schering |
| Noxafil | US5661151 | Tetrahydrofuran antifungals |
Jul 19, 2019
(Expired) | Merck Sharp Dohme |
| Noxafil | US6958337 | Crystalline antifungal polymorph |
Oct 05, 2018
(Expired) | Schering |
| Noxafil | US5703079 | Tetrahydrofuran antifungals |
Aug 26, 2014
(Expired) | Schering |
| Noxafil | US5703079 | Tetrahydrofuran antifungals |
Aug 26, 2014
(Expired) | Merck Sharp Dohme |
Posaconazole's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List